科学家开发有针对性的关节炎药物供应,减少炎症和副作用。 Scientists develop targeted drug delivery for arthritis, reducing inflammation and side effects.

印度纳米科技研究所的研究人员建立了一个新的风湿性关节炎药物供应系统,针对关节炎,仅在需要时才释放药物。 Researchers at India's Institute of Nano Science and Technology have created a new drug delivery system for rheumatoid arthritis that targets inflammation within joints, releasing medication only when needed. 在动物研究中,这种系统使用含有甲甲酸盐的微球显著减少胀和炎症. This system, using microspheres loaded with methotrexate, significantly reduced swelling and inflammation in animal studies. 它通过尽量减少副作用和减少对频繁注射的需要,提供了更安全、更有效的治疗。 It offers a safer, more effective treatment by minimizing side effects and reducing the need for frequent injections. 这一技术还可能有益于其他的发炎性疾病。 The technology could also benefit other inflammatory diseases.